Navigation Links
Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
Date:9/10/2008

PARIS, September 10 /PRNewswire-FirstCall/ --

- Abstracts 186 and 1003

Sanofi-aventis announced today that results from two studies, GINGER and LACE, presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD) demonstrated that a basal-bolus insulin regimen with LANTUS(R) (insulin glargine (rDNA origin) injection) once daily (basal insulin) and rapid-acting APIDRA(R) (insulin glulisine [rDNA origin] injection) at mealtime (bolus insulin) produced greater A1C reductions versus pre-mixed insulin in people with type 2 diabetes. Both studies, GINGER (a clinical trial) and LACE (real life patient data) confirmed the superior efficacy of LANTUS(R)/APIDRA(R) basal-bolus therapy when compared to pre-mixed insulin regimens.

Basal-bolus insulin regimens that combine once-daily LANTUS(R) as a basal insulin with rapid-acting APIDRA(R) at mealtime closely mimic normal physiologic insulin secretion that occurs in people without diabetes.

"Basal-bolus insulin regimens can be considered a gold standard for patients with late stage type 2 diabetes who have difficulty achieving glycemic targets with oral medications and/or basal insulin alone," explained study author Andreas Fritsche, MD, IVth Medical Department, University of Tübingen, Germany.

When compared to pre-mixed insulin regimens, the GINGER and LACE data demonstrate an efficacy advantage and, in the LACE study, a cost advantage for the basal-bolus approach.

The GINGER and the LACE data demonstrate an efficacy advantage and, in the LACE study, a cost advantage for the basal-bolus approach.

- The GINGER study ("52-Week, Open, Randomized, Multinational, Multicenter Clinical Trial Comparing Insulin Glulisine in Combination With Insulin Glargine in an Intensified Insulin Regimen to a Two-Injection Conventional Insulin Regimen in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control Pretreated With a Two-Injection Conventional Pre
'/>"/>

SOURCE Sanofi Aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
5. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. New Resource Available for People With Lymphoma
8. 38.7 Million People Break Guinness World Record for Stand Up Speak Out on International Day for the Eradication of Poverty
9. LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity
10. Treating Depression Prolongs Life for Older People with Diabetes
11. People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... April 27, 2015 Numerous Zofran birth defects ... the U.S. have highlighted serious concerns surrounding the use ... According to the U.S. Centers for Disease Control ... the market have enough information to determine their safety ... expectant mothers in the U.S. take at least one ...
(Date:4/27/2015)... NEW YORK , April 27, 2015   ... management solutions, will showcase advances in monitored care that ... the upcoming ATA 2015 Conference, May 2-5 ... Center. AMC Health will share information about ... monitored care to help transform and personalize healthcare delivery ...
(Date:4/27/2015)... Pa. , April 27, 2015  SCILEX ... and commercialization of products focused on the treatment ... team of William Stewart and ... important steps in SCILEX,s proprietary drug development program ... its products. The Company,s first product, ZTlido™ (lidocaine ...
Breaking Medicine Technology:Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 2Growing Zofran Birth Defects Litigation Highlights Concerns Surrounding Use of Prescription Medications During Pregnancy, According to Bernstein Liebhard LLP 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 2AMC Health to Showcase Advances in Monitored Care at ATA 2015 3AMC Health to Showcase Advances in Monitored Care at ATA 2015 4SCILEX Pharmaceuticals Announces Commercial Executive Appointments 2SCILEX Pharmaceuticals Announces Commercial Executive Appointments 3
(Date:4/27/2015)... "Understanding Mental Disorders: Your Guide to the ... Psychiatric Publishing, a division of the American Psychiatric Association. ... National Press Club in Washington, D.C.. The launch event ... President Paul Summergrad, MD. Guest speakers will include Former ... the book; Paul Gionfriddo, President and CEO of Mental ...
(Date:4/27/2015)... CA (PRWEB) April 27, 2015 On April ... to Get Rid of Stretch Marks ,” interviewed a ... marks . Stretch marks are a type of ... marks are caused by a breakdown of the elsastin and ... epidermis. (see: goo.gl/iRdmEe) , “Stretch mark removal with the ...
(Date:4/27/2015)... Beckman Coulter is sponsoring a ... the evolution of neural circuitry and swimming behavior of ... mechanisms by which analogous forms of swimming behavior, such ... independently in certain sea slug clades. The webinar is ... 30, 2015 at 8:00am PT. , Sea slugs (Mollusca, ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 Sitting or standing ... ache and feel tired, and for those whose occupation requires ... receptionists and taxi cab drivers, or to be on their ... hairdressers, the discomfort can be more severe and longer lasting. ... leg syndrome. Dr. Madaiah Revana of Northeast Houston Vein Center ...
(Date:4/27/2015)... FMC Corporation’s Health and Nutrition business announced ... market leading ingredients and solutions at Vitafoods Europe from ... Europe 2015 expects to host 14,000 attendees and 750 ... in such areas as digestive health, heart health, healthy ... Nutrition’s booth will feature its world leading Epax® brand ...
Breaking Medicine News(10 mins):Health News:American Psychiatric Association, Patrick Kennedy To Debut New Consumer Guidebook “Understanding Mental Disorders” 2Health News:Stretch Marks: The Latest Treatment Options for Stretch Mark Removal 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 2Health News:Beckman Coulter Genomics Presents Using Next-Gen Sequencing to Study the Evolution of Neural Circuitry 3Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3Health News:FMC Health and Nutrition to Feature Epax® Brand Omega-3 Ingredients at Vitafoods Europe 2015 2
... The developer of a product, known as ALKA-V6, a ... research as a potential cancer fighting weapon, has been named ... Arts at Texas State University. , Ignacius Cisneros, of Odessa, ... Alumni and business leaders. , In inviting Cisneros to participate, ...
... ... their shut-off products in an industrial gray color. , ... Loveland, CO (Vocus) October 30, 2009 -- Kent Systems is now ... offered were in patriotic red, white, and blue as well as black. The color selections ...
... , ... analyzes myths concerning alpine skiing injuries , ... Rosemont, IL (Vocus) October 30, 2009 -- Alpine skiing is ... crash videos replayed during the evening sports casts. However, a new study published in ...
... Findings from a new retrospective cohort study presented at ... in San Diego indicate that patients with Inflammatory Bowel ... medications to treat IBD, may be at risk for ... of the University of North Carolina, Chapel Hill, and ...
... ... increase the efficiency of inactivating 99.9% of the flu virus. The filter has been ... extracts. , ... CA (PRWEB) October 29, 2009 -- Coway ,s new anti-flu air filter ...
... 29 The Ensign Group, Inc. (Nasdaq: ENSG ... skilled nursing, rehabilitative care services, hospice care and assisted ... the Oppenheimer & Co. 20th Annual Healthcare Conference on ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071213/LATH168LOGO ) , Christopher Christensen, the ...
Cached Medicine News:Health News:Texas State University Names Developer of ALKA-V6 Compound to Board of Advisors 2Health News:Skiing Not As Dangerous as Believed 2Health News:Skiing Not As Dangerous as Believed 3Health News:Skiing Not As Dangerous as Believed 4Health News:Study reveals possible link between IBD therapy and skin cancer 2Health News:Coway Announces New Anti-Flu Air Filter Can Inactivate 2009 Seasonal Flu Virus 2Health News:The Ensign Group to Present at Oppenheimer 20th Annual Healthcare Conference 2
Double Ended Occluders...
Long handle occluders are approximately 9 inches long....
Manual Lensmeter....
Lightweight, cordless lensmeter....
Medicine Products: